Abbott Laboratories (ABT)
123.28
+0.73
(+0.60%)
USD |
NYSE |
Dec 11, 16:00
123.74
+0.46
(+0.37%)
Pre-Market: 09:18
Abbott Laboratories Research and Development Expense (Quarterly): 748.00M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Boston Scientific Corp. | 514.00M |
| Stryker Corp. | 398.00M |
| ResMed, Inc. | 87.32M |
| Baxter International, Inc. | 115.00M |
| Intuitive Surgical, Inc. | 329.40M |